Xinxia Chang

2.0k total citations
44 papers, 1.5k citations indexed

About

Xinxia Chang is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Xinxia Chang has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 14 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Molecular Biology. Recurrent topics in Xinxia Chang's work include Liver Disease Diagnosis and Treatment (25 papers), Diet, Metabolism, and Disease (12 papers) and Berberine and alkaloids research (7 papers). Xinxia Chang is often cited by papers focused on Liver Disease Diagnosis and Treatment (25 papers), Diet, Metabolism, and Disease (12 papers) and Berberine and alkaloids research (7 papers). Xinxia Chang collaborates with scholars based in China, Finland and Canada. Xinxia Chang's co-authors include Xin Gao, Hongmei Yan, Mingfeng Xia, Hua Bian, Xiaopeng Zhu, Daru Lu, Xiaoyang Sun, Minghong Jiang, Xi Xu and Huandong Lin and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Xinxia Chang

44 papers receiving 1.5k citations

Peers

Xinxia Chang
Xinxia Chang
Citations per year, relative to Xinxia Chang Xinxia Chang (= 1×) peers Anna Iacono

Countries citing papers authored by Xinxia Chang

Since Specialization
Citations

This map shows the geographic impact of Xinxia Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinxia Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinxia Chang more than expected).

Fields of papers citing papers by Xinxia Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinxia Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinxia Chang. The network helps show where Xinxia Chang may publish in the future.

Co-authorship network of co-authors of Xinxia Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Xinxia Chang. A scholar is included among the top collaborators of Xinxia Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinxia Chang. Xinxia Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Huang, Qingxia, S. U. Qadri, Hua Bian, et al.. (2024). A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver disease. Journal of Hepatology. 82(5). 781–793. 7 indexed citations
3.
Zhang, Yuying, Haifu Wu, Hongmei Yan, et al.. (2024). Characteristics of changes in plasma proteome profiling after sleeve gastrectomy. Frontiers in Endocrinology. 15. 1330139–1330139. 1 indexed citations
4.
Sun, Xiaoyang, Li Fan, Hongmei Yan, et al.. (2024). Intermittent compared with continuous calorie restriction for treatment of metabolic dysfunction-associated steatotic liver disease: a randomized clinical trial. American Journal of Clinical Nutrition. 121(1). 158–166. 5 indexed citations
5.
Dān, Wèi, Xinmei Wang, Jiaqi Wu, et al.. (2023). The early effects of sleeve gastrectomy on postprandial chylomicron triglycerides during the progression of type 2 diabetes. Clinica Chimica Acta. 549. 117558–117558. 1 indexed citations
6.
Tang, Qi, Bende Liu, Wenqing Zhang, et al.. (2022). A SARS-CoV-2 neutralizing antibody discovery by single cell sequencing and molecular modeling. Journal of Biomedical Research. 37(3). 166–166. 1 indexed citations
7.
Yan, Hongmei, Weiyun Wu, Xinxia Chang, et al.. (2021). Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism. Biology of Sex Differences. 12(1). 1–1. 25 indexed citations
8.
Guo, Liang, Yingying Guo, Baiyu Li, et al.. (2019). Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease. Journal of Biological Chemistry. 294(31). 11805–11816. 75 indexed citations
9.
Zhu, Xiaopeng, Hua Bian, Xiaoyang Sun, et al.. (2019). Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway. Free Radical Biology and Medicine. 141. 192–204. 197 indexed citations
10.
Wu, Haifu, et al.. (2017). [Prevention, diagnosis and treatment of perioperative complications of bariatric and metabolic surgery].. PubMed. 20(4). 393–397. 3 indexed citations
11.
Xia, Mingfeng, Hua Bian, Xiaopeng Zhu, et al.. (2017). Serum folic acid levels are associated with the presence and severity of liver steatosis in Chinese adults. Clinical Nutrition. 37(5). 1752–1758. 37 indexed citations
12.
Sun, Yixuan, Xinlu Yuan, Feifei Zhang, et al.. (2017). Berberine ameliorates fatty acid-induced oxidative stress in human hepatoma cells. Scientific Reports. 7(1). 11340–11340. 54 indexed citations
13.
Chang, Xinxia, Zhe Wang, Jinlan Zhang, et al.. (2016). Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease. Journal of Translational Medicine. 14(1). 266–266. 71 indexed citations
14.
Xia, Mingfeng, Hannele Yki‐Järvinen, Hua Bian, et al.. (2016). Influence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease. PLoS ONE. 11(8). e0160526–e0160526. 28 indexed citations
15.
Li, Qian, Weiyun Wu, Huandong Lin, et al.. (2016). Serum retinol binding protein 4 is negatively related to estrogen in Chinese women with obesity: a cross-sectional study. Lipids in Health and Disease. 15(1). 52–52. 8 indexed citations
16.
Yan, Hongmei, Mingfeng Xia, Xinxia Chang, et al.. (2015). Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease. PLoS ONE. 10(8). e0134172–e0134172. 180 indexed citations
17.
Chang, Xinxia, Hongmei Yan, Hua Bian, et al.. (2015). Serum retinol binding protein 4 is associated with visceral fat in human with nonalcoholic fatty liver disease without known diabetes: a cross-sectional study. Lipids in Health and Disease. 14(1). 28–28. 15 indexed citations
18.
Pan, Xingxiu, Xinxia Chang, Celeste Leung, et al.. (2015). PAK1 regulates cortical development via promoting neuronal migration and progenitor cell proliferation. Molecular Brain. 8(1). 36–36. 26 indexed citations
19.
Yan, Hongmei, Mingfeng Xia, Xinxia Chang, et al.. (2011). Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study. PLoS ONE. 6(9). e24895–e24895. 84 indexed citations
20.
Jiang, Minghong, Yuhao Zhang, Jing Fei, et al.. (2009). Rapid quantification of DNA methylation by measuring relative peak heights in direct bisulfite-PCR sequencing traces. Laboratory Investigation. 90(2). 282–290. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026